Navigation Links
Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease
Date:4/15/2009

rently in Phase 3 development for the treatment of Alzheimer's disease (AD) and in clinical development for Huntington's disease (HD). In preclinical models of AD and HD explored thus far, Dimebon has been shown to inhibit brain cell death, potentially by stabilizing and improving mitochondrial function in a way that prevents neuron death and dysfunction. The Dimebon mechanism is thought to be distinct from currently available AD medications.

Design of the CONCERT Study

The international, randomized, double-blind, placebo-controlled study will enroll approximately 1,050 patients with mild-to-moderate AD at approximately 100 sites in the United States, Australia, New Zealand and Western Europe. Patients on a stable dose of donepezil will be randomized to one of three treatment groups: Dimebon 20 mg three times per day, Dimebon 5 mg three times per day or placebo. Patients must be on treatment with donepezil for at least six months and at a stable dose of 10 mg daily for at least four months prior to enrollment in the study.

The primary endpoints are the Alzheimer's Disease Assessment Scale - cognitive subscale (ADAS-cog) and the Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL) - a measure of self-care and daily function.

For more information on the CONCERT study, please visit www.concertstudy.com or call 877-888-6386.

About Alzheimer's Disease

Alzheimer's disease is a progressive degenerative brain disorder that gradually destroys a person's memory and ability to learn, reason, make judgments, communicate and carry out daily activities. As the disease progresses, patients may experience changes in personality and behavior, such as anxiety, suspiciousness or agitation, as well as delusions or hallucinations.

About the Pfizer/Medivation Dimebon Collabor
'/>"/>

SOURCE Pfizer Inc; Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
2. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
3. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
4. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
5. MannKind Addresses Pfizers Announcement Regarding Exubera
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
8. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
9. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
10. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
11. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Md. , June 29, 2015 The ... New Jersey Board of Professional ... a provider of courses to professional engineers for continuing ... accreditation further demonstrates the value and quality of PDA,s ... . "Our lecture courses and hands-on professional training at ...
(Date:6/29/2015)... 29, 2015  Pressure BioSciences, Inc. (OTCQB: PBIO) ... development and sale of broadly enabling, pressure cycling ... life sciences industry, today announced that Tiannan Guo, ... Biology, ETH Zurich, presented data on an improved ... prostate cancer tissue biopsy samples at the recent ...
(Date:6/29/2015)... , June 29, 2015  The automotive ... features to cars on the basis of consumer ... industry is now on the verge of integrating ... While automotive HWW non-critical features such as reconfigurable ... present in 30 to 40 percent of all ...
Breaking Medicine Technology:Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 4Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... LLC, a leader in bioanalytical systems for drug discovery, ... launch of the MicroMax Low Volume Microplate which offers ... per plate on the SpectraMax® microplate readers. ... to test 24 or 64 samples per plate and ...
... 8, 2011 PREMICE clinical trial ... and points out that Cefaly® has the best ... On Monday 7th of November a press conference ... principal investigator, neurologist and professor at Liege University ...
Cached Medicine Technology:Molecular Devices Launches the MicroMax Low Volume Microplate, the Highest Throughput Low Volume Solution Available 2Breakthrough in Migraine Treatment 2
(Date:6/29/2015)... ... June 29, 2015 , ... FACE is proud to ... clients for the reduction of the double chin and redefining of the jawline. ... to look much older and heavier causing the person distress and poor self-image. , ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... and behavior, is a popular focus for corporate training seminars. As many as ... practices, improve training, foster teamwork, and increase productivity. , With the demand ...
(Date:6/29/2015)... ... 29, 2015 , ... Care to Care, LLC has appointed Leonard A. Farber, ... lead the Radiation Oncology Services Program, with a focus on innovations that foster new ... proprietary evidence based criteria. He will assist Dr. Julian Safir, Care to Care’s ...
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... Discovering: An Accessible US Travel Guide for Wheelchair Users as a new e-book ... use wheelchairs. , These accessible travel suggestions were crowdsourced by the ...
(Date:6/29/2015)... ... June 29, 2015 , ... BaliniSports has been announced as an official ... place later this year. This year’s contestants will be wearing pieces from the BaliniSports ... Nevada competition will go on to represent the state in the Miss Teen USA ...
Breaking Medicine News(10 mins):Health News:FACE Detroit Skin and Wellness Clinic Introduces Newly FDA Approved Kybella for the elimination of the Double Chin. 2Health News:As Demand for DISC Trainers Rises, PeopleKeys Offers Support with “THE DISC FACTOR—Train the Trainer” Webinar 2Health News:Care to Care, LLC Appoints a New Section Chief of Radiation Oncology 2Health News:Care to Care, LLC Appoints a New Section Chief of Radiation Oncology 3Health News:Wheel:Life Publishes Accessible US Travel Guidebook for Wheelchair Users 2Health News:Wheel:Life Publishes Accessible US Travel Guidebook for Wheelchair Users 3Health News:BaliniSports Announced as Sponsor of the Miss Teen Nevada 2016 Competition 2
... moms seek help for symptoms, , , WEDNESDAY, April 1 (HealthDay ... more likely to have developed moderate to severe depression within ... a single baby, say U.S. researchers who analyzed data from ... "Our findings suggest that 19 percent of mothers of multiples ...
... Fox Chase Cancer Center became the first hospital in ... detect prostate cancer using Invivo Equipment in a clinical ... Fox Chase is offering a new procedure for men ... at least two negative transrectal ultrasound guided (TRUS) biopsies ...
... Companies, Health Care ProvidersLIBERTYVILLE, Ill., April 1 ... sales and marketing solutions, today announced the acquisition ... of online, on-demand prescription drug sampling. Under the ... of Physicians Interactive LLC. Terms of the acquisition ...
... Country Gather to Discuss Interactive Patient Care, Patient ... GetWellNetwork, Inc., the leading provider ... its highly successful conference, GetConnected2009 ... GetConnected2009 is the industry,s leading ...
... 5:00 p.m. EDT -- SOUTH SAN FRANCISCO, Calif., ... SNSS ) today announced the execution of a securities ... placement of up to $43.5 million in a tranched ... preferred stock and common stock warrants, and a tranche ...
... resources to quit smoking for a healthier lifestylePHILADELPHIA, April 1 ... gone up to just over a dollar with the increase ... push smokers need to kick the habit. Independence Blue Cross ... products.Quitting smoking not only saves money, it saves lives. Approximately ...
Cached Medicine News:Health News:Mothers of Multiples May Face Higher Depression Risk 2Health News:Physicians Interactive Acquires MedManage Systems 2Health News:Physicians Interactive Acquires MedManage Systems 3Health News:Innovation and Sharing of Client Successes Highlight GetWellNetwork's GetConnected2009 Conference 2Health News:Innovation and Sharing of Client Successes Highlight GetWellNetwork's GetConnected2009 Conference 3Health News:Innovation and Sharing of Client Successes Highlight GetWellNetwork's GetConnected2009 Conference 4Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 2Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 3Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 4Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 5Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 6Health News:Smokers Have Greater Incentive to Quit, as Big Tobacco Tax Hike Goes Into Effect Today 2Health News:Smokers Have Greater Incentive to Quit, as Big Tobacco Tax Hike Goes Into Effect Today 3
Solid lower plate with outside width 15 mm. Open serrated upper plate with inside dimensions 9 x 12 mm. Serrated handle with locking thumb screw and polished finish....
Narrow smooth jaws. Serrated handle with polished finish....
14 mm oval solid lower plate and straight 9 mm serrated upper jaw. Locking thumb screw and serrated handle with polished finish....
Round solid 10 mm wide lower plate. Open upper plate with inside diameter 8 mm. Serrated handle with locking thumb screw and polished finish. Most popular size or model....
Medicine Products: